Evaluate is the trusted provider of life science commercial intelligence and consensus forecasts to 2022. We help our clients make high value decisions through superior quality, timely, data and personalised, expert support. Our online subscription services cover the pharmaceutical, biotech and medtech sectors. Evaluate Custom Services delivers project-based data and analysis. EP Vantage, our independent, award-winning editorial team provides daily commentary and analysis.